- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
Capabilities
King & Spalding’s Private Equity practice is well-versed in fund formation, mergers and acquisitions, acquisition finance, compliance issues, securities offerings, tax, and other related issues. We advise clients on transactions in the U.S. and throughout the world, including Europe, Asia, Africa, South America and the Middle East. We also offer deep industry experience in industry sectors such as energy, healthcare, life sciences, real estate and technology.
Our Private Equity team helps clients execute the investment, M&A and financing transactions that are integral to private equity investment and exit strategies. We have led hundreds of such transactions, ranging in size from less than $25 million to more than $25 billion.
We work across all industry sectors, with particular concentration in:
- transactional and regulatory work in energy markets — domestic and international;
- U.S. healthcare companies involved in the delivery of healthcare and payment for healthcare services, as well as pharmaceutical, biotech and medical device companies;
- private real estate investment funds; and
- transactional and regulatory work in the technology sector.
Our Private Equity lawyers are experienced in organizing private investment funds and fund management companies. We have complementary depth in separately advising portfolio company management on its participation in buyouts and other private equity investments by funds. Our employee benefits and tax lawyers also help portfolio company managers achieve their equity incentive and compensation objectives over the life of a fund’s investment.
Our fund, geographical and investment cycle footprint is inclusive. We advise buyout funds, real estate funds, sovereign wealth funds, venture capital funds, and other alternative investment vehicles and other private equity investors doing business in the North American, Latin American, European, Middle Eastern, Russian and Asian markets.
Throughout the investment cycle, we assist them in connection with their control and minority investments, including:
- initial acquisitions;
- divestitures;
- add-on acquisitions;
- financings; and
- exit transactions, including dispositions, IPOs and complex recapitalizations.
Related Lawyers
Insights
Client Alert
February 26, 2021
Financial Services Industry Back Under Congress’ Microscope
Client Alert
February 26, 2021
Tracking Employee Vaccinations Globally: Can You Obtain The COVID-19 Vaccination Status Of Your Employees Everywhere?
Article
February 12, 2021
King & Spalding Discusses SEC’s Potential Focus During Biden Administration
Close
Recognition
King & Spalding earned a Top 20 ranking for Global Private Equity by volume in 2016
Bloomberg
Named Best Advisory Firm for Fund Structuring in 2016
MENA Fund Manager
Ranked as one of the most active law firms in the U.S. representing general partners or limited partners
The Private Equity Analyst
Respected for work across a range of practices including life sciences, technology and energy
Chambers USA
Our Middle East/Islamic Finance Practice is one of the leading such practices in the world
Included in top rankings for Corporate/M&A and Venture Capital Investments
Chambers USA
News
Press Release
February 22, 2021
King & Spalding’s New York Office Adds Financial Services Partner Russell Sacks
Press Release
January 26, 2021
Top Healthcare Partner Richard Zall Joins King & Spalding in New York
Recognition
November 16, 2020
Legal Week Names Macky O’Sullivan a Rising Star at Middle East Awards 2020
Cases & Deals
January 29, 2021
Axium Infrastructure to Acquire UPPCO